Analyzing Shiseido (SSDOY) and Its Competitors

Shiseido (OTCMKTS: SSDOY) is one of 484 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare Shiseido to similar businesses based on the strength of its dividends, institutional ownership, profitability, analyst recommendations, earnings, risk and valuation.

Earnings & Valuation

This table compares Shiseido and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Shiseido $8.97 billion $202.92 million 43.42
Shiseido Competitors $2.03 billion $132.97 million -3.56

Shiseido has higher revenue and earnings than its peers. Shiseido is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.


This table compares Shiseido and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Shiseido 2.18% 15.66% 6.89%
Shiseido Competitors -3,102.79% -153.66% -26.80%

Risk and Volatility

Shiseido has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, Shiseido’s peers have a beta of 1.08, suggesting that their average share price is 8% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Shiseido and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shiseido 0 0 0 0 N/A
Shiseido Competitors 2763 8493 21284 569 2.59

As a group, “Pharmaceutical preparations” companies have a potential upside of 44.31%. Given Shiseido’s peers higher possible upside, analysts clearly believe Shiseido has less favorable growth aspects than its peers.


Shiseido pays an annual dividend of $0.21 per share and has a dividend yield of 0.3%. Shiseido pays out 14.6% of its earnings in the form of a dividend. As a group, “Pharmaceutical preparations” companies pay a dividend yield of 2.1% and pay out 31.8% of their earnings in the form of a dividend.

Insider and Institutional Ownership

0.1% of Shiseido shares are held by institutional investors. Comparatively, 47.0% of shares of all “Pharmaceutical preparations” companies are held by institutional investors. 15.3% of shares of all “Pharmaceutical preparations” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.


Shiseido beats its peers on 7 of the 12 factors compared.

About Shiseido

Shiseido Company, Limited produces and sells cosmetics, cosmetics accessories, and toiletries in Japan and internationally. It also produces and sells health and beauty foods, and over-the-counter drugs; and beauty salon products. In addition, the company operates beauty salons, as well as restaurants. Further, it produces and sells cosmetic raw materials, medical-use drugs, medical cosmetics, purification/analytical equipment, and other products. The company sells its products through cosmetic specialty stores, department stores, general merchandise stores, drug stores, and perfumeries, as well as through mail-order. Shiseido Company, Limited was founded in 1872 and is headquartered in Tokyo, Japan.

Receive News & Ratings for Shiseido Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shiseido and related companies with's FREE daily email newsletter.

Leave a Reply